Cure My Disease

Don't miss your cure!

 Log in / Sign up

New monitor aims to catch health declines in nursing homes before they worsen

NCT ID NCT06270953

Knowledge-focused Sponsor: Turtle Shell Technologies Pvt. Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a device called Dozee Pro NX that continuously monitors heart rate, breathing, oxygen levels, and movement without touching the patient. It was used in skilled nursing and assisted living facilities to see if it helps staff spot health problems earlier. The goal was to reduce emergency visits and hospital stays while improving care efficiency.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dozee Pro NX device
What this could lead to
If successful, this could lead to better and faster detection of health declines in nursing homes, potentially reducing hospital transfers and improving patient safety.
What could go wrong
This was a small, completed study with only 54 participants and no specific medical condition, so results may not apply broadly. The device's impact on real-world outcomes remains uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

54 people

The number who actually took part.

Started

Jan 2024

Finished

Jun 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will be conducted on subjects in the age group above 18 years regardless of gender. The study is done on patients admitted in the SNF who fulfill the inclusion and exclusion criteria

Ages

18 months to 120 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Weight between 40kg-120kgs Exclusion Criteria: * Terminal illness with a life expectancy of less than 1 month. * Have any condition that could interfere with the subject's ability to lie flat or stable on the bed * Needs the use of equipment whose operation can interfere with Investigation System operations * Patients planned to be transferred from the facility within 72 hours * Prisoners * Pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for No specific medical conditions or disease states are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

No specific medical conditions or disease states

Contacts and locations

Locations

  • Oak Village Healthcare

    Lake Jackson, Texas, 77566, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.